Manning & Napier Group, LLC Biogen Inc. Transaction History

Manning & Napier Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 24, 2019	SELL	$278.5 - $352.75 $49.7 Million - $63 Million	-178,560 Closed	0 $0
Q3 2018 Oct 10, 2018	SELL	$293.51 - $383.83 $11.4 Million - $14.9 Million	-38,930 Reduced 17.9%	178,560 $63.1 Million
Q2 2018 Jul 13, 2018	SELL	$257.52 - $306.91 $44.5 Million - $53 Million	-172,760 Reduced 44.27%	217,490 $63.1 Million
Q1 2018 May 01, 2018	SELL	$260.13 - $367.91 $4.27 Million - $6.03 Million	-16,403 Reduced 4.03%	390,250 $107 Million
Q4 2017 Feb 05, 2018	BUY	$307.64 - $344.58 $125 Million - $140 Million	406,653	406,653 $130 Million

995

131M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Manning & Napier Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Manning & Napier Group, LLC with notifications on news.